Authors: Kurosumi, M Suemasu, K Tabei, T Inoue, K Matsumoto, H Sugamata, N Higashi, Y

Citation: M. Kurosumi et al., Relationship between existence of lymphatic invasion in peritumoral breasttissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast, ONCOL REP, 8(5), 2001, pp. 1051-1055

Authors: Kurosumi, M Tabei, T Suemasu, K Inoue, K Kusawake, T Sugamata, N Higashi, Y

Citation: M. Kurosumi et al., Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients, ONCOL REP, 7(5), 2000, pp. 945-948

Authors: Koibuchi, Y Sugamata, N Iino, Y Yokoe, T Andoh, T Maemura, M Takei, H Horiguchi, J Matsumoto, H Morishita, Y

Citation: Y. Koibuchi et al., The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7,12-dimethylbenz(a)anthracene-induced rat mammary cancer, INT J MOL M, 4(2), 1999, pp. 145-148

Authors: Sugamata, N Koibuchi, Y Iino, Y Morishita, Y

Citation: N. Sugamata et al., A novel aromatase inhibitor, vorozole, shows antitumor activity and a decrease of tissue insulin-like growth factor-I level in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors, INT J ONCOL, 14(2), 1999, pp. 259-263